These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27392656)

  • 21. [Clinical research outside of teaching hospitals: Current situation in north-eastern France].
    Goetz C; Dupoux A; Déloy L; Hertz C; Jeanmaire T; Parneix N
    Rev Epidemiol Sante Publique; 2015 Apr; 63(2):135-41. PubMed ID: 25818919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Demography of radiation oncology residents in France in 2008: current situation and perspectives for the next three years].
    Dewas S; Pointreau Y; Rivera S; Blanchard P; Vautravers C; Marchand V; Mahe MA; Mazeron JJ; Kantor G
    Cancer Radiother; 2009 Jun; 13(3):153-60. PubMed ID: 19268618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What you Need to Know about the New Regulations for Biomedical Research in France.
    Tillet Y; Lebrun A
    Therapie; 2006; 61(6):467-70. PubMed ID: 27393047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Not Available].
    Hénin Y; Boischevalier Bd; Reboul-Salze F; Cracowski JL; Dualé C;
    Therapie; 2010; 65(2):71-94. PubMed ID: 27393075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early results from a multi-component French public-private partnership initiative to improve participation in clinical research - CeNGEPS: a prospective before-after study.
    Bordet R; Lang M; Dieu C; Billon N; Duffet JP
    BMC Med Res Methodol; 2015 Aug; 15():67. PubMed ID: 26286263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
    Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
    Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Future challenges and prospects for drug companies].
    Lajoux C
    Bull Acad Natl Med; 2008 Apr; 192(4):623-30; discussion 630-2. PubMed ID: 19024935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Information sheets and informed consent forms for clinical study participants: towards standardised recommendations?
    Chassany O; Bernard-Harlaut M; Guy G; Billon N
    Therapie; 2009; 64(3):161-86. PubMed ID: 19671429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The pharmaceutical industry during the Second World War: issues and evolution].
    Bonnemain B
    Rev Hist Pharm (Paris); 2002; 50(336):629-46. PubMed ID: 12712987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [State of unmet medical needs in France in 2006: necessity of reinforcing research effort].
    Jouan-Flahault C; Billon N; Castaigne A; Henry YD; Omnes C; Puech A; Rosilio M; Lassale C
    Therapie; 2007; 62(5):393-415. PubMed ID: 18206102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of the French Research Institute for Overseas Development (Institut de Recherche pour le Developpement, IRD)].
    Girard JF
    Bull Acad Natl Med; 2008 Feb; 192(2):275-8; discussion 278-80. PubMed ID: 18819682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
    Ekimoto H
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to improve the clinical development paradigm and its division into phases I, II and III.
    Bamberger M; Moore N; Lechat P;
    Therapie; 2011; 66(4):331-4, 327-30. PubMed ID: 21851796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of the impact of randomised clinical trials on surgical practice in France. French Associations for Research in Surgery (AURC and ACAPEM). Association Universitaire de Recherche en Chirurgie. Association des Chirurgiens de l'Assistance Publique pour l'Evaluation Médicale.
    Millat B; Fingerhut A; Flamant Y; Hay JM; Fagniez PL; Farah A; Duron JJ; Courchevel JM
    Eur J Surg; 1999 Feb; 165(2):87-94. PubMed ID: 10192564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contracts including performance and management of uncertainty].
    Duru G; Garassus P; Auray JP
    Ann Pharm Fr; 2013 Sep; 71(5):338-45. PubMed ID: 24075704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trends and evolutions of French breast cancer research: a bibliometric study].
    Thonon F; Saghatchian M; Nerfie A; Delaloge S
    Bull Cancer; 2015 May; 102(5):417-27. PubMed ID: 25887175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of the use of dermoscopy in academic and non-academic hospital centres in France: a nationwide survey.
    Breton AL; Amini-Adle M; Duru G; Poulalhon N; Dalle S; Thomas L
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1207-13. PubMed ID: 23998395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.